KalVista Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q4 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
KalVista Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2014 to Q2 2024.
  • KalVista Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending July 31, 2024 was 43.1M shares, a 25.7% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 43.1M +8.82M +25.7% Jul 31, 2024 10-Q 2024-09-05
Q1 2024 42.5M +8.35M +24.4% Apr 30, 2024 10-Q 2024-09-05
Q4 2023 34.6M +468K +1.37% Jan 31, 2024 10-Q 2024-03-11
Q3 2023 34.4M +9.82M +39.9% Oct 31, 2023 10-Q 2023-12-07
Q2 2023 34.3M +9.7M +39.5% Jul 31, 2023 10-Q 2023-09-07
Q1 2023 34.2M +9.62M +39.2% Apr 30, 2023 10-K 2024-07-11
Q4 2022 34.1M +9.59M +39.1% Jan 31, 2023 10-Q 2023-03-09
Q3 2022 24.6M +159K +0.65% Oct 31, 2022 10-Q 2022-12-08
Q2 2022 24.6M +133K +0.55% Jul 31, 2022 10-Q 2022-09-08
Q1 2022 24.6M +128K +0.53% Apr 30, 2022 10-K 2023-07-10
Q4 2021 24.5M +6.52M +36.2% Jan 31, 2022 10-Q 2022-03-10
Q3 2021 24.4M +6.53M +36.4% Oct 31, 2021 10-Q 2021-12-09
Q2 2021 24.4M +6.56M +36.7% Jul 31, 2021 10-Q 2021-09-09
Q1 2021 24.4M +6.58M +36.9% Apr 30, 2021 10-K 2022-07-07
Q4 2020 18M +176K +0.98% Jan 31, 2021 10-Q 2021-03-11
Q3 2020 17.9M +81.4K +0.46% Oct 31, 2020 10-Q 2020-12-10
Q2 2020 17.9M +64.9K +0.36% Jul 31, 2020 10-Q 2020-09-14
Q1 2020 17.8M +568K +3.29% Apr 30, 2020 10-K 2021-07-13
Q4 2019 17.8M +598K +3.47% Jan 31, 2020 10-Q 2020-03-10
Q3 2019 17.8M +609K +3.54% Oct 31, 2019 10-Q 2019-12-03
Q2 2019 17.8M +7.02M +65% Jul 31, 2019 10-Q 2019-09-09
Q1 2019 17.3M +6.48M +60% Apr 30, 2019 10-K 2020-07-01
Q4 2018 17.2M +6.45M +59.8% Jan 31, 2019 10-Q 2019-03-14
Q3 2018 17.2M +6.44M +59.7% Oct 31, 2018 10-Q 2018-12-14
Q2 2018 10.8M +1.09M +11.2% Jul 31, 2018 10-Q 2018-09-14
Q1 2018 10.8M +1.09M +11.2% Apr 30, 2018 10-K 2019-07-16
Q4 2017 10.8M +1.08M +11.1% Jan 31, 2018 10-Q 2018-03-16
Q3 2017 10.8M -15.6M -59.1% Oct 31, 2017 10-Q 2017-12-14
Q2 2017 9.71M -16.6M -63.1% Jul 31, 2017 10-Q 2017-09-14
Q1 2017 9.71M -16.6M -63.1% Apr 30, 2017 10-K 2018-07-30
Q4 2016 9.71M -16.6M -63.1% Jan 31, 2017 10-Q 2017-03-16
Q3 2016 26.3M +21.6K +0.08% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 26.3M +13.3K +0.05% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 26.3M +25.6M +3617% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 26.3M +25.6M +3708% Dec 31, 2015 10-Q 2016-11-08
Q3 2015 26.3M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 26.3M Jun 30, 2015 10-Q 2015-08-13
Q1 2015 708K Mar 31, 2015 10-Q 2015-05-21
Q4 2014 691K Dec 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.